Franco Mantero Selected Research

Insulin Resistance

1/2014	A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea.
1/2010	Hypertension in Cushing's syndrome: from pathogenesis to treatment.
1/2007	Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
2/2006	Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Franco Mantero Research Topics

Disease

38	Adenoma (Adenomas) 01/2018 - 05/2003
30	Hyperaldosteronism (Conn Syndrome) 01/2018 - 03/2002
25	Neoplasms (Cancer) 10/2018 - 01/2002
21	Hypertension (High Blood Pressure) 12/2019 - 08/2003
20	Cushing Syndrome 01/2018 - 11/2002
7	Hyperplasia 01/2016 - 09/2008
6	Adrenal incidentaloma 01/2018 - 11/2002
6	Adrenocortical Carcinoma 10/2016 - 09/2005
6	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2013 - 06/2002
5	Pituitary ACTH Hypersecretion 07/2014 - 12/2004
5	Pituitary Neoplasms (Pituitary Adenoma) 01/2014 - 09/2003
5	Pheochromocytoma 08/2007 - 01/2005
4	Insulin Resistance 01/2014 - 02/2006
4	Obesity 09/2006 - 01/2002
3	Essential Hypertension 01/2018 - 08/2005
3	Carcinogenesis 10/2016 - 01/2002
3	Hypokalemia 01/2016 - 09/2008
3	Carcinoma (Carcinomatosis) 09/2013 - 12/2004
3	Papillary Thyroid Cancer 12/2011 - 01/2008
2	Necrosis 01/2014 - 09/2013
2	Autoimmune Diseases (Autoimmune Disease) 12/2013 - 06/2002
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2013 - 06/2002
2	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2013 - 08/2012
2	Overweight 07/2008 - 05/2002
2	Addison Disease (Addison's Disease) 05/2006 - 04/2004
2	ACTH-Secreting Pituitary Adenoma 02/2006 - 01/2004
2	Asthenozoospermia 09/2005 - 01/2004
2	Acromegaly 01/2005 - 09/2003
2	Body Weight (Weight, Body) 05/2004 - 01/2002
2	Alkalosis 08/2003 - 03/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2018
1	Liddle Syndrome 01/2018
1	Atrial Fibrillation 01/2018
1	Lung Neoplasms (Lung Cancer) 10/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2014
1	Polycythemia (Erythrocytosis) 01/2014

Drug/Important Bio-Agent (IBA)

34	AldosteroneIBA 12/2019 - 05/2003
22	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2019 - 01/2002
11	ReninIBA 12/2019 - 04/2005
9	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2015 - 01/2002
8	GlucocorticoidsIBA 01/2013 - 11/2002
7	Hormones (Hormone)IBA 01/2016 - 05/2003
5	AutoantibodiesIBA 01/2015 - 06/2002
5	MineralocorticoidsIBA 02/2014 - 08/2003
5	SteroidsIBA 12/2011 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
4	Mineralocorticoid Receptor AntagonistsIBA 01/2016 - 09/2008
4	Dexamethasone (Maxidex)FDA LinkGeneric 10/2015 - 01/2002
4	Mitotane (Lysodren)FDA Link 01/2013 - 09/2005
4	Captopril (Capoten)FDA LinkGeneric 09/2010 - 04/2006
4	Messenger RNA (mRNA)IBA 01/2008 - 05/2002
3	Cortisone FDA Link 01/2018 - 02/2014
3	EnzymesIBA 01/2015 - 06/2002
3	Codon (Codons)IBA 05/2014 - 01/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 05/2011 - 09/2003
2	CateninsIBA 10/2016 - 01/2016
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2016 - 10/2014
2	Antihypertensive Agents (Antihypertensives)IBA 04/2015 - 01/2010
2	AndrogensIBA 10/2014 - 01/2013
2	Oxidoreductases (Dehydrogenase)IBA 02/2014 - 09/2006
2	Everolimus FDA Link 01/2014 - 08/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 09/2005
2	Etoposide (VP 16)FDA LinkGeneric 06/2012 - 09/2005
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012 - 09/2005
2	Biological ProductsIBA 03/2012 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2012 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 12/2011 - 10/2010
2	von Willebrand FactorIBA 01/2011 - 01/2008
2	nasIBA 07/2010 - 09/2005
2	SodiumIBA 07/2008 - 08/2007
2	IodineIBA 01/2008 - 11/2003
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2007 - 03/2006
2	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 08/2005 - 08/2003
2	Corticotropin Receptors (ACTH Receptor)IBA 05/2003 - 01/2002
1	CatecholaminesIBA 12/2019
1	ElectrolytesIBA 12/2019
1	Nonsense Codon (Nonsense Mutation)IBA 10/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	SNS 314IBA 10/2016
1	Aurora KinasesIBA 10/2016
1	VX (EDIM)IBA 10/2016
1	tozasertibIBA 10/2016
1	Serine (L-Serine)FDA Link 10/2016
1	4- (4- (N- benzoylamino)anilino)- 6- methoxy- 7- (3- (1- morpholino)propoxy)quinazolineIBA 10/2016
1	Threonine (L-Threonine)FDA Link 10/2016
1	Cadherins (E-Cadherin)IBA 10/2016
1	reversanIBA 10/2016
1	ImmunosorbentsIBA 01/2015
1	Type 1 Angiotensin ReceptorIBA 01/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2014
1	FITC-annexin A5IBA 01/2014
1	Propidium (Propidium Iodide)IBA 01/2014
1	Temozolomide (Temodar)FDA LinkGeneric 01/2014

Therapy/Procedure

13	Adrenalectomy 01/2018 - 10/2004
11	Therapeutics 01/2018 - 06/2002
2	Glycemic Control 01/2014 - 05/2008
2	Radiotherapy 05/2011 - 09/2004
2	Length of Stay 08/2007 - 06/2007